OrthoPediatrics Corp.
KIDSHealthcareNASDAQMedical Devices · Last scanned Jun 1, 2026
Scan Results
Daily timeframeOrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic. The $441.0M market capitalization puts KIDS squarely in small-cap range for its industry. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity in children; and sports medicine and other products.
Market Cap
$441.0M
Beta
0.99
P/E (TTM)
—
P/E (Fwd)
-25.25
EPS (TTM)
$-1.68
EPS (Fwd)
$-0.68
ROE
-11.6%
ROA
-3.4%
Cash
$48.8M
Total Debt
$112.2M
Free CF
-$6.0M
52W Change
-14.0%
Annual Financials
Cash vs Debt
The company holds $48.8M in cash, though total debt stands at $112.2M. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. The company is burning cash, with free cash flow at -$6.0M. This typically occurs when a company is investing aggressively in growth, but sustained cash burn can strain the balance sheet. Return on equity stands at -11.6%, which is negative for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. Revenue has grown from $122.3M (2022) to $236.3M (2025), reflecting a 93% increase over the period.
Negative free cash flow means the company is currently spending more than it generates, which may require future fundraising or debt if the trend continues. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence OrthoPediatrics Corp.'s trajectory.